<DOC>
	<DOCNO>NCT02650856</DOCNO>
	<brief_summary>The investigator include patient schedule total knee arthroplasty diagnosis osteoarthritis . The patient divide two group . In group verbal clear detail information give intraoperative approach . The first group receive topical tranexamic acid second group topical platelet rich plasma ; surgical site . Both group assess intervention clinical scale ( VAS ) laboratory result ( hemoglobin , hematocrit level ) transfusion rate .</brief_summary>
	<brief_title>Blood Loss Reduction After Total Knee Arthroplasty . A Comparison Between Topical Tranexamic Acid Platelet Rich Plasma</brief_title>
	<detailed_description>Total knee replacement ( TKR ) surgery one common orthopaedic procedure world . Morbility perioperative TKR associate : blood loss , pain , infection , wound complication , stiffness thrombotic event . Blood loss transfusion associate increase hospital stay , cost , morbility mortality patient . Indications blood transfusion limit well know free risk procedure . Complications ; ABO incompatibility , viral transmission , hemolysis , immunosuppression wound infection report . Literature report report blood loss TKR range 300ml 1 liter , transfusion rate vary 10-38 % . In diminish hospital cost Moskal J. et al report 53.90 % saving 100 % reduction work hour hospital staff use topical tranexamic acid TKR . Tranexamic acid antifibrinolytic agent act inhibit plasminogen , stabilize blood clot ; use stop surgical traumatic bleeding like CRASH-2 trial , demonstrate efficiency polytraumatized patient . Tranexamic acid use last year blood loss good result . Due systemic effect past medical history myocardial infarction , stent previous thromboembolic event intravenous use limit . In study investigator use topical tranexamic acid use proven clinical trial secure strategy por blood loss reduction TKR , without exclude patient previous thromboembolic event . Platelet rich plasma ( PRP ) orthobiologic play important role past decade different area like ; spinal fusion , ACL reconstruction , osteoarthrosis tendinopathies . The use platelet rich plasma ( PRP ) orthopaedics overrate true indication use cost benefit still unclear . Retrospective study like Pace T et al 268 patient demonstrate difference hospital stay , Postoperative hemoglobin level , range motion use PRP TKR . Morishita M. Et al clinical trial 40 patient , use intralesional PRP didn´t show benefit blood loss reduction TKR , good clinical result observe clinical score like KOOS VAS compare control group . Other study demonstrate efficacy topical PRP blood loss reduction TKR . Due high platelet concentration growth factor contain alfa granule ; use hemostatic , analgesic antiseptic agent TKR . There variety blood loss prevention strategy TKR strategy divide preoperative , intraoperative postoperative . The aim study compare use topical tranexamic acid versus topical platelet rich plasma . An Insall knee approach , parapatellar medial use patient . After final cut femoral , tibial patellar place final cement component experimental intervention study begin . Group 1 . A dosis 2 gr tranexamic acid ( 1000mg/10mL X-GEN pharmaceutical inc. ) dilute 80mL physiologic solution divide two application : First application : 40mL solution previously prepare applied surgical site leave five minute drain completely suction . Second application : The rest 40mL solution previously prepare applied place final TKR cement component ( femoral , tibial patellar ) , surgical site leave without drain suction . Group 2 . In preoperative room previous premedication , total 55cc total venous blood obtain forearm ( cubital basilic vein ) . The blood carry 12 steriles tube use sodium citrate 3.8 % anticoagulant ( BD , Vacutainer ; Becton , Dickinson Company , NJ ) . Blood sample transport Bank Tissue ( Banco de hueso Dr. José E. Gonzalez ) centrifugation 1800 rpm 10 minute ( HeraeusMegafuge 1.0R ; ThermoElectronCorporation ) separation 3 layer ( White , yellow red ) . The superior layer rich plasma collect 50 microliters polypropylene tube ( Corning , NY ) . A final volumen 16 ml platelet rich plasma obtain transfer airtight tube ( BD Vacutainer ; Becton , Dickinson Company , NJ ) . The manipulation blood sample make laminar flow cabin biosecurity class II ( Logic 3440801 ; Labconco , KC ) . The platelet rich plasma activate calcium gluconate 10 % ( Pisa Farmacéutica , Jalisco , México ) use place surgical site topically . The PRP simple divide two application , initiate intervention final cut TKR component ( like tranexamic acid group ) . First application : 8 mL PRP apply surgical site leave five minute drain completely suction . Second application : The rest 8 mL apply surgical site place final TKR cement component ( femoral , tibial patellar ) , surgical site leave without drain . Then primary closure wound perform ( capsule , fascia , subcutaneous tissue skin ) group . A close drainage ( Drenovac , NEdren S de R.L . de C.V. ) leave intraarticular fixed skin . The drainage clamp 2 hour remove 48 hour surgery . Thromboprophylaxis ( low weight heparin ) initiate 6 hour end surgery . In postoperative follow , patient hemoglobin level less 9mg/dl anemic syndrome transfuse .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Tranexamic Acid</mesh_term>
	<criteria>1 . Age &gt; 18 year 2 . Patient candidate primary total knee replacement 3 . Patients willing participate study sign de inform consent 1 . Patients previous history thromboembolic event last 6 month 2 . Patients candidate revision total knee replacement 3 . Patients candidate tumoral total knee replacement 4 . Patients candidate bilateral total knee replacement 5 . Patient cognitive deficit 6 . Previous history coagulopathy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Blood loss</keyword>
	<keyword>Tranexamic acid</keyword>
	<keyword>Platelet rich plasma</keyword>
	<keyword>Total knee arthroplasty</keyword>
</DOC>